Pharmaceutical composition for treating gout and reducing urea acid and preparation method thereof

Abstract

The invention relates to a pharmaceutical composition for treating gout and reducing urea acid and a preparation method thereof. The pharmaceutical composition is prepared from the following Chinese herbal medicines of vitex root, nodus pini, Chinese fir, radix scrophulariae, radix angelicae pubescentis, rhizoma seu radix notopterygii, radix gentianae macrophyllae, syngnathus, hippocampus, radix clematidis, poria cocos, semen coicis, pawpaw, radix achyranthis bidentatae, cortex acanthopanacis, herba taxilli and semen plantaginis. The pharmaceutical composition has the advantages that the decoction or ethyl alcohol (rice wine) extracting liquid (medicine wine) is used for treating gout; after three doses of pharmaceutical composition are orally administrated, the pain is relieved; after five doses of pharmaceutical composition are administrated, the pain is eliminated; after the pharmaceutical composition is continuously administrated for one month, the urea acid value is reduced to normal value, namely clinically healing; the medicine directly reaches focus of infection, so that the redness, swelling and pain of the focus of infection of the patient are eliminated, the urea acid is exhausted out of a human body, and the purpose of treating gout is realized; any obvious toxic or side effect is avoided; the defects of palliatives, unthorough pain relieving, and toxic or side effect in the existing gout treatment medicine are overcome.

Description

technical field [0001] The invention relates to a pharmaceutical composition for treating gout and reducing uric acid and a preparation method thereof. Background technique [0002] Gout is a recurrent attack caused by increased purine biosynthesis and metabolism, excessive uric acid production or poor excretion of uric acid, resulting in elevated uric acid in the blood and deposition of urate crystals in the synovium, synovial bursa, cartilage and other tissues Inflammatory diseases. It is a group of heterogeneous diseases caused by monosodium urate crystallization or supersaturation of uric acid in extracellular fluid, resulting in the deposition of crystals in tissues. The disease is characterized by birefringent sodium urate monohydrate crystals found in joint fluid and tophi. Its clinical features are: characteristic acute arthritis caused by hyperuricemia and urate crystals and deposits, tophi, interstitial nephritis, joint deformity and dysfunction in severe cases, ...

AI Technical Summary

Problems solved by technology

[0041] The purpose of the present invention is to provide a pharmaceutical composition that can not only eliminate redness, swelling and pain, but also reduce uric acid and treat gout and its preparation method, which overcomes the current chemical medicines and Chinese herbal medicines that treat gout by treating the symptoms but not the root cause, incomplete analgesia, and toxic side effects. Shortcomings